Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients
- 7 September 2016
- journal article
- review article
- Published by Wiley in Transplant Infectious Disease
- Vol. 18 (6), 819-831
- https://doi.org/10.1111/tid.12601
Abstract
Appropriate post‐transplant immunosuppressive regimens that avoid acute rejection, while reducing risk of viral reactivation, have been sought, but remain a chimera. Recent evidence suggesting potential regulatory and antiviral effects of mammalian target of rapamycin inhibitors (mTORi) is of great interest. Although the concept of an immunosuppressive drug with antiviral properties is not new, little effort has been made to put the evidence together to assess the management of immunosuppressive therapy in the presence of a viral infection. This review was developed to gather the evidence on antiviral activity of the mTORi against the viruses that most commonly reactivate in adult solid organ recipients: cytomegalovirus (CMV), polyomavirus, Epstein‐Barr virus (EBV), human herpesvirus 8 (HHV8), and hepatitis C virus (HCV). A rapid review methodology and evaluation of quality and consistency of evidence based on the GRADE system was used. The existing literature was variable in nature, although indicating a potential advantage of mTORi in CMV, polyomavirus, and HHV8 infection, and a most doubtful relation with EBV and HCV infection. Several recommendations about the management of these infections are presented that can change certain current patterns of immunosuppression and help to improve the prognosis of the direct and indirect effects of viral infection in solid organ recipients.Keywords
Funding Information
- Novartis Pharma
This publication has 102 references indexed in Scilit:
- BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibitionBMC Nephrology, 2013
- mTOR inhibitors in pediatric kidney transplantationPediatric Nephrology, 2013
- Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanismsReviews in Medical Virology, 2012
- Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled TrialAmerican Journal of Transplantation, 2012
- The Changing Role of mTOR Kinase in the Maintenance of Protein Synthesis during Human Cytomegalovirus InfectionJournal of Virology, 2011
- Potential use of rapamycin in HIV infectionBritish Journal of Clinical Pharmacology, 2010
- Expediting systematic reviews: methods and implications of rapid reviewsImplementation Science, 2010
- Timing of sirolimus conversion influences recovery of renal function in liver transplant recipientsClinical Transplantation, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Viral Infection after Renal TransplantationClinical Journal of the American Society of Nephrology, 2008